- Home
- LPCN vs VIVK Comparison
LPCN vs VIVK Comparison
Compare LPCN & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- VIVK
- Stock Information
- Founded
- LPCN 1997
- VIVK 2006
- Country
- LPCN United States
- VIVK United States
- Employees
- LPCN N/A
- VIVK N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- VIVK Oilfield Services/Equipment
- Sector
- LPCN Health Care
- VIVK Energy
- Exchange
- LPCN Nasdaq
- VIVK Nasdaq
- Market Cap
- LPCN 18.2M
- VIVK 20.9M
- IPO Year
- LPCN N/A
- VIVK N/A
- Fundamental
- Price
- LPCN $2.60
- VIVK $0.23
- Analyst Decision
- LPCN Strong Buy
- VIVK
- Analyst Count
- LPCN 1
- VIVK 0
- Target Price
- LPCN $8.00
- VIVK N/A
- AVG Volume (30 Days)
- LPCN 59.9K
- VIVK 83.3M
- Earning Date
- LPCN 11-07-2025
- VIVK 11-18-2025
- Dividend Yield
- LPCN N/A
- VIVK N/A
- EPS Growth
- LPCN N/A
- VIVK N/A
- EPS
- LPCN N/A
- VIVK N/A
- Revenue
- LPCN $4,208,119.00
- VIVK $124,048,464.00
- Revenue This Year
- LPCN N/A
- VIVK N/A
- Revenue Next Year
- LPCN N/A
- VIVK N/A
- P/E Ratio
- LPCN N/A
- VIVK N/A
- Revenue Growth
- LPCN N/A
- VIVK 98.83
- 52 Week Low
- LPCN $2.57
- VIVK $0.18
- 52 Week High
- LPCN $6.17
- VIVK $1.68
- Technical
- Relative Strength Index (RSI)
- LPCN 32.60
- VIVK 38.69
- Support Level
- LPCN $2.75
- VIVK $0.25
- Resistance Level
- LPCN $2.92
- VIVK $0.48
- Average True Range (ATR)
- LPCN 0.14
- VIVK 0.10
- MACD
- LPCN -0.05
- VIVK 0.02
- Stochastic Oscillator
- LPCN 4.69
- VIVK 12.76
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.